List of insiders holdings for HOOKIPA Pharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GILEAD SCIENCES INC. 10% Owner | 2023-12-22 16:18:56 | 18,759,465 0 | 18,759,465 | Form 13G |
| BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN Former 10% owner | 2024-06-14 18:52:27 | 9,813,151 0 | 9,813,151 | Form 13D |
| SOFINNOVA CAPITAL VI FCPR Sofinnova Partners SAS 10% Owner | 2023-02-13 13:34:23 | 3,142,596 0 | 3,142,596 | Form 13D |
| Redmile Group LLC Green Jeremy 10% Owner | 2024-02-14 16:26:22 | 1,063,769 0 | 1,063,769 | Form 13G |
| Aldag Jorn Chief Executive Officer | 2024-04-17 16:15:27 | 971,400 0 | 971,400 | Form 4 |
| Kandera Reinhard Chief Financial Officer | 2024-04-17 16:15:19 | 406,200 0 | 406,200 | Form 4 |
| Orlinger Klaus Chief Scientific Officer | 2024-04-17 16:15:29 | 367,300 0 | 367,300 | Form 4 |
| Necina Roman Chief Operations Officer | 2024-04-17 16:15:11 | 367,300 0 | 367,300 | Form 4 |
| Winderlich Mark Chief Development Officer | 2024-04-17 16:15:25 | 300,000 0 | 300,000 | Form 4 |
| Baker Christine D. Chief Operating Officer | 2023-04-18 19:47:32 | 275,800 0 | 275,800 | Form 4 |
| Schlienger Katia Chief Medical Officer | 2023-04-18 19:48:30 | 184,000 0 | 184,000 | Form 4 |
| Pinschewer David Chief Scientific Officer | 2019-04-24 18:14:30 | 116,416 0 | 116,416 | Form 4 |
| Peters Malte Chief Executive Officer | 2024-07-24 16:17:16 | 108,695 0 | 108,695 | Form 4 |
| van de Winkel Jan Director | 2024-06-18 16:15:32 | 98,000 0 | 98,000 | Form 4 |
| Matushansky Igor Chief Medical Officer | 2022-07-01 16:11:01 | 92,950 0 | 92,950 | Form 4 |
| Coelho Mary Theresa EVP and CFO | 2024-07-24 16:18:15 | 69,875 0 | 69,875 | Form 4 |
| Reilly Timothy P. Director | 2024-06-18 16:15:15 | 49,000 0 | 49,000 | Form 4 |
| O'Neill Julie Director | 2024-06-18 16:15:21 | 49,000 0 | 49,000 | Form 4 |
| Kaufman David Ross Director | 2024-06-18 16:15:32 | 49,000 0 | 49,000 | Form 4 |
| Kelly Michael Aaron Director | 2022-07-01 16:09:41 | 20,000 0 | 20,000 | Form 4 |
| Lilja Anders Sr. VP, Technical Development | 2020-01-27 16:52:34 | 13,098 0 | 13,098 | Form 4 |
| Cassidy Sean A Director | 2024-07-24 16:16:22 | 9,800 0 | 9,800 | Form 4 |
| Soria Jean-Charles Director | 2021-06-04 20:37:46 | 9,600 0 | 9,600 | Form 4 |
| Lengauer Christoph Director | 2021-06-04 20:35:41 | 9,600 0 | 9,600 | Form 4 |
| van Deventer Sander Director | 2020-10-23 16:03:48 | 2,485 0 | 2,485 | Form 4 |
| Forbion Capital Fund II Cooperatief U.A. 10% Owner | 2022-02-11 09:18:59 | 966 0 | 966 | Form 13G |
| Seghezzi Graziano Director | 2021-06-14 16:31:18 | 0 0 | 0 | Form 4/A |